Report overview
Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products.
This report contains market size and forecasts of Ovarian Cancer Therapeutics in Global, including the following market information:
Global Ovarian Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ovarian Cancer Therapeutics market was valued at 1815.3 million in 2021 and is projected to reach US$ 2580.9 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PARP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ovarian Cancer Therapeutics include Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals, Genentech Inc., Astra Zeneca, Boehringer Ingelheim GmbH and Hoffmann La Roche Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ovarian Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ovarian Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ovarian Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
PARP
PD-L1
Angiogenesis Inhibitors
Global Ovarian Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ovarian Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hosptial
Research
Global Ovarian Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ovarian Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ovarian Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ovarian Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals
Genentech Inc.
Astra Zeneca
Boehringer Ingelheim GmbH
Hoffmann La Roche Ltd.
